M. Stephen Meyn

10.5k total citations · 2 hit papers
77 papers, 5.3k citations indexed

About

M. Stephen Meyn is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, M. Stephen Meyn has authored 77 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 33 papers in Genetics and 18 papers in Cancer Research. Recurrent topics in M. Stephen Meyn's work include DNA Repair Mechanisms (31 papers), Genomics and Rare Diseases (19 papers) and Genomic variations and chromosomal abnormalities (18 papers). M. Stephen Meyn is often cited by papers focused on DNA Repair Mechanisms (31 papers), Genomics and Rare Diseases (19 papers) and Genomic variations and chromosomal abnormalities (18 papers). M. Stephen Meyn collaborates with scholars based in Canada, United States and United Kingdom. M. Stephen Meyn's co-authors include Cynthia Timmers, Markus Grompe, Terry Ashley, Alan D. D’Andrea, Shridar Ganesan, Toshiyasu Taniguchi, Irene García-Higuera, James Hejna, Yang Xu and David Baltimore and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

M. Stephen Meyn

76 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

2001 978 citations M. Stephen Meyn et al. profile →
Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.

1996 696 citations M. Stephen Meyn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Stephen Meyn Canada	32	4.2k	1.4k	1.3k	1.2k	490	77	5.3k
Quinten Waisfisz Netherlands	36	4.4k 1.0×	1.5k 1.1×	1.4k 1.0×	773 0.7×	469 1.0×	89	5.5k
Mark O’Driscoll United Kingdom	32	4.5k 1.1×	1.1k 0.8×	1.1k 0.8×	1.5k 1.3×	279 0.6×	59	5.3k
Sjaak Philipsen Netherlands	45	6.1k 1.5×	1.2k 0.8×	813 0.6×	716 0.6×	231 0.5×	122	8.2k
Nicolaas G.J. Jaspers Netherlands	31	4.4k 1.1×	792 0.6×	1.2k 0.9×	705 0.6×	276 0.6×	57	4.8k
Miria Stefanini Italy	42	4.8k 1.1×	868 0.6×	1.3k 1.0×	717 0.6×	278 0.6×	116	5.3k
Paul R. Andreassen United States	45	5.8k 1.4×	1.2k 0.8×	1.2k 0.9×	1.6k 1.3×	692 1.4×	101	6.8k
Tej K. Pandita United States	46	5.2k 1.3×	544 0.4×	969 0.7×	1.3k 1.1×	379 0.8×	125	6.4k
Kurtis E. Bachman United States	30	6.5k 1.6×	1.1k 0.8×	1.2k 0.9×	1.4k 1.2×	148 0.3×	51	7.6k
Peter J. Stambrook United States	40	3.6k 0.9×	887 0.6×	713 0.5×	1.4k 1.2×	168 0.3×	111	4.9k
Galit Rotman Israel	31	3.8k 0.9×	495 0.3×	1.3k 1.0×	1.4k 1.2×	207 0.4×	50	4.7k

Countries citing papers authored by M. Stephen Meyn

Since Specialization

Citations

This map shows the geographic impact of M. Stephen Meyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Stephen Meyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Stephen Meyn more than expected).

Fields of papers citing papers by M. Stephen Meyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Stephen Meyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Stephen Meyn. The network helps show where M. Stephen Meyn may publish in the future.

Co-authorship network of co-authors of M. Stephen Meyn

This figure shows the co-authorship network connecting the top 25 collaborators of M. Stephen Meyn. A scholar is included among the top collaborators of M. Stephen Meyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Stephen Meyn. M. Stephen Meyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakano, Yoshiko, Harriet Druker, M. Stephen Meyn, et al.. (2024). Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance. European Journal of Human Genetics. 32(11). 1474–1482. 1 indexed citations

Hayeems, Robin Z., Stephanie Luca, Lauren Chad, et al.. (2023). Assessing the Performance of the Clinician-reported Genetic Testing Utility InDEx (C-GUIDE): Further Evidence of Inter-rater Reliability. Clinical Therapeutics. 45(8). 729–735. 2 indexed citations

Hayeems, Robin Z., Stephanie Luca, Anna Hurst, et al.. (2022). Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity. European Journal of Human Genetics. 30(12). 1423–1431. 9 indexed citations

Khan, Tayyaba, Meredith Curtis, Eyal Cohen, et al.. (2022). Pharmacogenetic profiling via genome sequencing in children with medical complexity. Pediatric Research. 93(4). 905–910. 6 indexed citations

Walker, Susan, Sylvia Lamoureux, Tayyaba Khan, et al.. (2021). Genome sequencing for detection of pathogenic deep intronic variation: A clinical case report illustrating opportunities and challenges. American Journal of Medical Genetics Part A. 185(10). 3129–3135. 13 indexed citations

Cohn, Iris, Tara Paton, Christian R. Marshall, et al.. (2017). Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study. npj Genomic Medicine. 2(1). 19–19. 38 indexed citations

Hayeems, Robin Z., Jasmin Bhawra, Kate Tsiplova, et al.. (2017). Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray. European Journal of Human Genetics. 25(12). 1303–1312. 27 indexed citations

Anderson, James A., M. Stephen Meyn, Cheryl Shuman, et al.. (2016). Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?. Journal of Medical Ethics. 43(8). 535–539. 60 indexed citations

Larsen, Andrew, et al.. (2016). FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway. Human Molecular Genetics. 25(15). 3255–3268. 42 indexed citations

10.

Williams, Brent A., M. Stephen Meyn, & Johann Hitzler. (2011). Transient Leukemia in Newborns Without Down Syndrome. Journal of Pediatric Hematology/Oncology. 33(6). e261–e263. 8 indexed citations

11.

Milyavsky, Michael, Olga I. Gan, Magan Trottier, et al.. (2010). A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal. Cell stem cell. 7(2). 186–197. 209 indexed citations

12.

Breakey, Vicky R., M. Stephen Meyn, Vicky L. Ng, et al.. (2009). Hepatitis-associated Aplastic Anemia Presenting as a Familial Bone Marrow Failure Syndrome. Journal of Pediatric Hematology/Oncology. 31(11). 884–887. 5 indexed citations

13.

Buchanan, Janet A., Andrew R. Carson, David Chitayat, et al.. (2009). The cycle of genome-directed medicine. Genome Medicine. 1(2). 16–16. 7 indexed citations

14.

Pavenski, Katerina, Lucie Dupuis, Shelley Kennedy, et al.. (2002). Detecting rearrangements in children using subtelomeric FISH and SKY. American Journal of Medical Genetics. 107(4). 267–274. 46 indexed citations

15.

Meyn, M. Stephen, et al.. (2001). TEL1 from Saccharomyces cerevisiae suppresses chromosome aberrations induced by ionizing radiation in ataxia-telangiectasia cells without affecting cell cycle checkpoints. Radiation and Environmental Biophysics. 40(4). 309–315. 2 indexed citations

16.

Fritz, Eberhard, Anna A. Friedl, Ralf M. Zwacka, Friederike Eckardt‐Schupp, & M. Stephen Meyn. (2000). The YeastTEL1Gene Partially Substitutes for HumanATMin Suppressing Hyperrecombination, Radiation-Induced Apoptosis and Telomere Shortening in A-T Cells. Molecular Biology of the Cell. 11(8). 2605–2616. 25 indexed citations

17.

Meyn, M. Stephen. (1997). Correspondence re: M. Stephen Meyn, Ataxia Telangiectasia and Cellular Responses to DNA Damage. Cancer Res., 55: 5991–6001, 1995—Reply. Cancer Research. 57(11). 2314–2315. 2 indexed citations

18.

Teebi, Ahmad S., Lisa H. Gibson, James McGrath, et al.. (1993). Molecular and cytogenetic characterization of 9p– abnormalities. American Journal of Medical Genetics. 46(3). 288–292. 43 indexed citations

19.

Rossman, Toby G., M. Stephen Meyn, & Walter Troll. (1977). Effects of arsenite on DNA repair in Escherichia coli. Environmental Health Perspectives. 19. 229–233. 46 indexed citations

20.

Rossman, Toby G., M. Stephen Meyn, & Walter Troll. (1975). Effects of sodium arsenite on the survival of UV-irradiated Escherichia Coli: INHIBITION OF A rec A-Dependent function. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 30(2). 157–161. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact